Call For Papers
The ICOCTD aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Oncology, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Emerging cancer therapeutics and treatments
- Novel drug development in oncology
- Combination therapies for cancer
- Immunotherapy advancements in cancer care
- Targeted therapies in oncology
- Challenges in cancer drug approval
- Role of clinical trials in therapeutics
- Patient access to new treatments
- Biomarkers in therapeutic decision-making
- Pharmacogenomics in cancer treatment
- Cost-effectiveness of cancer therapies
- Innovations in radiation oncology
- Palliative care and cancer therapeutics
- Ethical considerations in drug development
- Role of technology in cancer therapeutics
- Long-term outcomes of cancer treatments
- Global access to cancer therapies
- Patient adherence to cancer treatment
- Future trends in cancer therapeutics
- Collaboration in drug development research
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.